{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T16:08:31Z","timestamp":1792512511437,"version":"4.5.0"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T00:00:00Z","timestamp":1764633600000},"content-version":"vor","delay-in-days":1,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002701","name":"Korea Ministry of Education","doi-asserted-by":"publisher","award":["DJR2025\\u201301"],"award-info":[{"award-number":["DJR2025\\u201301"]}],"id":[{"id":"10.13039\/501100002701","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["RS-2023-KH138733"],"award-info":[{"award-number":["RS-2023-KH138733"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.biopha.2025.118876","type":"journal-article","created":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T17:36:06Z","timestamp":1765474566000},"page":"118876","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["In silico virtual screening of natural small molecules for dual inhibition of A\u03b2 and tau aggregation in Alzheimer's disease"],"prefix":"10.1016","volume":"193","author":[{"given":"Sujin","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1518-196X","authenticated-orcid":false,"given":"Vijay","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo Jung","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunkwon","family":"Nam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong Ho","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sinae","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun Young","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0540-4739","authenticated-orcid":false,"given":"Dong Hyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8140-5928","authenticated-orcid":false,"given":"Minho","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9349","key":"10.1016\/j.biopha.2025.118876_bib1","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1016\/S0140-6736(02)11920-9","article-title":"Mild cognitive impairment in older people","volume":"360","author":"Burns","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2025.118876_bib2","article-title":"Alzheimer's disease","volume":"1","author":"Masters","year":"2015","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"4","key":"10.1016\/j.biopha.2025.118876_bib3","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1001\/jamaneurol.2013.5847","article-title":"Amyloid-beta and tau: the trigger and bullet in Alzheimer disease pathogenesis","volume":"71","author":"Bloom","year":"2014","journal-title":"JAMA Neurol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118876_bib4","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s40035-025-00479-4","article-title":"Dual modulation of amyloid beta and tau aggregation and dissociation in Alzheimer's disease: a comprehensive review of the characteristics and therapeutic strategies","volume":"14","author":"Nam","year":"2025","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.biopha.2025.118876_bib5","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.actbio.2024.06.001","article-title":"Carbon dots as dual inhibitors of tau and amyloid-beta aggregation for the treatment of Alzheimer's disease","volume":"183","author":"Zhang","year":"2024","journal-title":"Acta Biomater."},{"issue":"2","key":"10.1016\/j.biopha.2025.118876_bib6","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s00401-014-1371-2","article-title":"Tau aggregation and its interplay with amyloid-b","volume":"129","author":"Nisbet","year":"2015","journal-title":"Acta Neuropathol."},{"issue":"10","key":"10.1016\/j.biopha.2025.118876_bib7","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1038\/s41593-020-0687-6","article-title":"Synergy between amyloid-beta and tau in Alzheimer's disease","volume":"23","author":"Busche","year":"2020","journal-title":"Nat. Neurosci."},{"issue":"1","key":"10.1016\/j.biopha.2025.118876_bib8","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s40035-025-00465-w","article-title":"Second-generation anti-amyloid monoclonal antibodies for Alzheimer's disease: current landscape and future perspectives","volume":"14","author":"Kim","year":"2025","journal-title":"Transl. Neurodegener."},{"issue":"11","key":"10.1016\/j.biopha.2025.118876_bib9","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.3390\/pharmaceutics17111417","article-title":"Amodiaquine modulates aggregation and disassembly of amyloid-\u03b2 and Tau and attenuates neuroinflammatory responses and A\u03b2 production","volume":"17","author":"Jang","year":"2025","journal-title":"Pharmaceutics"},{"issue":"6","key":"10.1016\/j.biopha.2025.118876_bib10","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.1700488","article-title":"Selective targeting of primary and secondary nucleation pathways in Abeta42 aggregation using a rational antibody scanning method","volume":"3","author":"Aprile","year":"2017","journal-title":"Sci. Adv."},{"issue":"1","key":"10.1016\/j.biopha.2025.118876_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27010233","article-title":"Role of phenolic compounds in human disease: current knowledge and future prospects","volume":"27","author":"Rahman","year":"2021","journal-title":"Molecules"},{"issue":"4","key":"10.1016\/j.biopha.2025.118876_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/nu14040819","article-title":"Phenolic acids and prevention of cognitive decline: polyphenols with a neuroprotective role in cognitive disorders and Alzheimer's disease","volume":"14","author":"Caruso","year":"2022","journal-title":"Nutrients"},{"issue":"6","key":"10.1016\/j.biopha.2025.118876_bib13","doi-asserted-by":"crossref","first-page":"12411","DOI":"10.3390\/ijms140612411","article-title":"Protein folding and aggregation into amyloid: the interference by natural phenolic compounds","volume":"14","author":"Stefani","year":"2013","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2025.118876_bib14","doi-asserted-by":"crossref","DOI":"10.1186\/s12576-022-00845-1","article-title":"Antioxidative properties of phenolic compounds and their effect on oxidative stress induced by severe physical exercise","volume":"72","author":"Kruk","year":"2022","journal-title":"J. Physiol. Sci."},{"issue":"8","key":"10.1016\/j.biopha.2025.118876_bib15","doi-asserted-by":"crossref","DOI":"10.1111\/cns.14885","article-title":"Natural compounds from herbs and nutraceuticals as glycogen synthase kinase-3beta inhibitors in Alzheimer's disease treatment","volume":"30","author":"Zhao","year":"2024","journal-title":"CNS Neurosci. Ther."},{"issue":"10","key":"10.1016\/j.biopha.2025.118876_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21103561","article-title":"Polyphenols with anti-amyloid beta aggregation show potential risk of toxicity via pro-oxidant properties","volume":"21","author":"Kobayashi","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2025.118876_bib17","article-title":"Natural products targeting Tau protein phosphorylation: a promising therapeutic avenue for Alzheimer's disease","author":"Chen","year":"2025","journal-title":"Planta Med."},{"issue":"7","key":"10.1016\/j.biopha.2025.118876_bib18","doi-asserted-by":"crossref","first-page":"5892","DOI":"10.1074\/jbc.M404751200","article-title":"Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo","volume":"280","author":"Yang","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2025.118876_bib19","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/8152373","article-title":"Neuroprotective mechanisms of resveratrol in Alzheimer's disease: role of SIRT1","volume":"2018","author":"Gomes","year":"2018","journal-title":"Oxid. Med. Cell Longev."},{"issue":"3","key":"10.1016\/j.biopha.2025.118876_bib20","doi-asserted-by":"crossref","first-page":"999","DOI":"10.3233\/JAD-170351","article-title":"Curcumin inhibits Tau aggregation and disintegrates preformed Tau filaments in vitro","volume":"60","author":"Rane","year":"2017","journal-title":"J. Alzheimers Dis."},{"issue":"6","key":"10.1016\/j.biopha.2025.118876_bib21","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/nsmb.1437","article-title":"EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers","volume":"15","author":"Ehrnhoefer","year":"2008","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"30","key":"10.1016\/j.biopha.2025.118876_bib22","doi-asserted-by":"crossref","first-page":"5990","DOI":"10.1021\/bi300113x","article-title":"Morin inhibits the early stages of amyloid beta-peptide aggregation by altering tertiary and quaternary interactions to produce \"off-pathway\" structures","volume":"51","author":"Lemkul","year":"2012","journal-title":"Biochemistry"},{"issue":"6","key":"10.1016\/j.biopha.2025.118876_bib23","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1111\/j.1471-4159.2010.06875.x","article-title":"Development of a grape seed polyphenolic extract with anti-oligomeric activity as a novel treatment in progressive supranuclear palsy and other tauopathies","volume":"114","author":"Pasinetti","year":"2010","journal-title":"J. Neurochem."},{"issue":"7958","key":"10.1016\/j.biopha.2025.118876_bib24","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/s41586-023-05905-z","article-title":"Computational approaches streamlining drug discovery","volume":"616","author":"Sadybekov","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2025.118876_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116226","article-title":"Dual regulatory effects of neferine on amyloid-beta and tau aggregation studied by in silico, in vitro, and lab-on-a-chip technology","volume":"172","author":"Nam","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2025.118876_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115770","article-title":"Genipin and pyrogallol: two natural small molecules targeting the modulation of disordered proteins in Alzheimer's disease","volume":"168","author":"Kim","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2025.118876_bib27","article-title":"Dual modulators of aggregation and dissociation of amyloid beta and tau: in vitro, in vivo, and in silico studies of Uncaria rhynchophylla and its bioactive components","volume":"156","author":"Kim","year":"2022","journal-title":"Biomed. Pharmaother."},{"issue":"13","key":"10.1016\/j.biopha.2025.118876_bib28","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1002\/jcc.10306","article-title":"Detailed analysis of grid-based molecular docking: a case study of CDOCKER-A CHARMm-based MD docking algorithm","volume":"24","author":"Wu","year":"2003","journal-title":"J. Comput. Chem."},{"issue":"9","key":"10.1016\/j.biopha.2025.118876_bib29","doi-asserted-by":"crossref","first-page":"4066","DOI":"10.1021\/acs.jmedchem.5b00104","article-title":"pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures","volume":"58","author":"Pires","year":"2015","journal-title":"J. Med. Chem."},{"issue":"20-21","key":"10.1016\/j.biopha.2025.118876_bib30","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.csbj.2014.09.011","article-title":"Cell-based models to investigate tau aggregation","volume":"12","author":"Lim","year":"2014","journal-title":"Comput. Struct. Biotechnol. J."},{"issue":"3","key":"10.1016\/j.biopha.2025.118876_bib31","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3109\/13506129.2014.929103","article-title":"Inhibition of tau aggregation by a rosamine derivative that blocks tau intermolecular disulfide cross-linking","volume":"21","author":"Haque","year":"2014","journal-title":"Amyloid"},{"issue":"1","key":"10.1016\/j.biopha.2025.118876_bib32","doi-asserted-by":"crossref","first-page":"87","DOI":"10.2174\/1874070700802010087","article-title":"Synthesis and purification of highly hydrophobic peptides derived from the C-terminus of amyloid beta-protein","volume":"2","author":"Condron","year":"2008","journal-title":"Open Biotechnol. J."},{"issue":"12","key":"10.1016\/j.biopha.2025.118876_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens11121559","article-title":"Hexameric aggregation nucleation core sequences and diversity of pathogenic tau strains","volume":"11","author":"Wu","year":"2022","journal-title":"Pathogens"},{"issue":"51","key":"10.1016\/j.biopha.2025.118876_bib34","doi-asserted-by":"crossref","first-page":"48165","DOI":"10.1074\/jbc.M105196200","article-title":"Mutations of tau protein in frontotemporal dementia promote aggregation of paired helical filaments by enhancing local beta-structure","volume":"276","author":"von Bergen","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.biopha.2025.118876_bib35","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1023\/A:1008130001697","article-title":"Property distribution of drug-related chemical databases","volume":"14","author":"Oprea","year":"2000","journal-title":"J. Comput. Aided Mol. Des."},{"issue":"1","key":"10.1016\/j.biopha.2025.118876_bib36","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/s42004-025-01587-y","article-title":"Structure-based discovery of forsythoside A as an effective inhibitor to reduce the neurotoxicity of amyloid b","volume":"8","author":"Bai","year":"2025","journal-title":"Commun. Chem."},{"issue":"5","key":"10.1016\/j.biopha.2025.118876_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1004258","article-title":"Structural conversion of abeta17-42 peptides from disordered oligomers to U-shape protofilaments via multiple kinetic pathways","volume":"11","author":"Cheon","year":"2015","journal-title":"PLOS Comput. Biol."},{"key":"10.1016\/j.biopha.2025.118876_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2025.118527","article-title":"Taurine suppresses A\u03b2 aggregation and attenuates Alzheimer\u2019s disease pathologies in 5XFAD mice and patient-derived cerebral organoids","volume":"191","author":"Lee","year":"2025","journal-title":"Biomed. Pharmacother."},{"issue":"4","key":"10.1016\/j.biopha.2025.118876_bib39","doi-asserted-by":"crossref","first-page":"805","DOI":"10.3390\/neurolint16040060","article-title":"Artificial intelligence as a replacement for animal experiments in neurology: potential, progress, and challenges","volume":"16","author":"Rudroff","year":"2024","journal-title":"Neurol. Int."},{"issue":"9","key":"10.1016\/j.biopha.2025.118876_bib40","doi-asserted-by":"crossref","first-page":"4144","DOI":"10.1021\/acs.jcim.0c00113","article-title":"Augmenting hit identification by virtual screening techniques in small molecule drug discovery","volume":"60","author":"Yan","year":"2020","journal-title":"J. Chem. Inf. Model."},{"issue":"1","key":"10.1016\/j.biopha.2025.118876_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.aichem.2023.100039","article-title":"Advances in artificial intelligence (AI)-assisted approaches in drug screening","volume":"2","author":"Singh","year":"2024","journal-title":"Artif. Intell. Chem."},{"issue":"1","key":"10.1016\/j.biopha.2025.118876_bib42","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202100542","article-title":"Recent advances in the prediction of pharmacokinetics properties in drug design studies: a review","volume":"17","author":"Pantaleao","year":"2022","journal-title":"ChemMedChem"},{"key":"10.1016\/j.biopha.2025.118876_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2025.160423","article-title":"Minimizing late-stage failure in drug development with transformer models: enhancing drug screening and pharmacokinetic predictions","author":"Khambhawala","year":"2025","journal-title":"Chem. Eng. J."},{"issue":"3","key":"10.1016\/j.biopha.2025.118876_bib44","doi-asserted-by":"crossref","first-page":"585","DOI":"10.3233\/JAD-2009-1083","article-title":"Cinnamon extract inhibits tau aggregation associated with Alzheimer's disease in vitro","volume":"17","author":"Peterson","year":"2009","journal-title":"J. Alzheimers Dis."},{"issue":"48","key":"10.1016\/j.biopha.2025.118876_bib45","doi-asserted-by":"crossref","first-page":"16251","DOI":"10.1074\/jbc.RA119.012330","article-title":"Gallic acid is a dual alpha\/beta-secretase modulator that reverses cognitive impairment and remediates pathology in Alzheimer mice","volume":"295","author":"Mori","year":"2020","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2025.118876_bib46","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.bbr.2016.05.052","article-title":"The flavonoid baicalein rescues synaptic plasticity and memory deficits in a mouse model of Alzheimer's disease","volume":"311","author":"Gu","year":"2016","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.biopha.2025.118876_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115159","article-title":"Genkwanin: an emerging natural compound with multifaceted pharmacological effects","volume":"165","author":"Menyiy","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"4","key":"10.1016\/j.biopha.2025.118876_bib48","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/cbic.201000604","article-title":"Baicalein inhibits formation of \u03b1-synuclein oligomers within living cells and prevents A\u03b2 peptide fibrillation and oligomerisation","volume":"12","author":"Lu","year":"2011","journal-title":"ChemBioChem"},{"key":"10.1016\/j.biopha.2025.118876_bib49","doi-asserted-by":"crossref","first-page":"3145","DOI":"10.2147\/NDT.S117469","article-title":"Baicalein improves behavioral dysfunction induced by Alzheimer's disease in rats","volume":"12","author":"Zhou","year":"2016","journal-title":"Neuropsychiatr. Dis. Treat."},{"issue":"9","key":"10.1016\/j.biopha.2025.118876_bib50","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1002\/jnr.23244","article-title":"Baicalein reduces \u03b2-amyloid and promotes nonamyloidogenic amyloid precursor protein processing in an Alzheimer's disease transgenic mouse model","volume":"91","author":"Zhang","year":"2013","journal-title":"J. Neurosci. Res."},{"issue":"4","key":"10.1016\/j.biopha.2025.118876_bib51","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.jtcme.2016.12.014","article-title":"Pharmacological properties of Salvia officinalis and its components","volume":"7","author":"Ghorbani","year":"2017","journal-title":"J. Tradit. Complement. Med."},{"issue":"1","key":"10.1016\/j.biopha.2025.118876_bib52","first-page":"35","article-title":"Phenols from the aerial parts of Leonurus sibiricus","volume":"58","author":"Pan","year":"2006","journal-title":"Chin. Pharm. J."},{"issue":"14","key":"10.1016\/j.biopha.2025.118876_bib53","doi-asserted-by":"crossref","first-page":"18993","DOI":"10.18632\/aging.203348","article-title":"A network pharmacology approach to uncover the key ingredients in Ginkgo Folium and their anti-Alzheimer's disease mechanisms","volume":"13","author":"Zeng","year":"2021","journal-title":"Aging"},{"issue":"5","key":"10.1016\/j.biopha.2025.118876_bib54","doi-asserted-by":"crossref","DOI":"10.3390\/nu10050589","article-title":"In Silico investigation of the pharmacological mechanisms of beneficial effects of Ginkgo biloba L. on Alzheimer's disease","volume":"10","author":"Li","year":"2018","journal-title":"Nutrients"},{"issue":"23","key":"10.1016\/j.biopha.2025.118876_bib55","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252312962","article-title":"2'-Hydroxycinnamaldehyde, a natural product from cinnamon, alleviates ischemia\/reperfusion-induced microvascular dysfunction and oxidative damage in rats by upregulating cytosolic BAG3 and Nrf2\/HO-1","volume":"25","author":"Cheng","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.biopha.2025.118876_bib56","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.nutres.2016.10.002","article-title":"Phenylpropanoids from cinnamon bark reduced beta-amyloid production by the inhibition of beta-secretase in Chinese hamster ovarian cells stably expressing amyloid precursor protein","volume":"36","author":"Kang","year":"2016","journal-title":"Nutr. Res."},{"key":"10.1016\/j.biopha.2025.118876_bib57","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.nbd.2018.11.009","article-title":"Gallic acid disruption of A\u03b21\u201342 aggregation rescues cognitive decline of APP\/PS1 double transgenic mouse","volume":"124","author":"Yu","year":"2019","journal-title":"Neurobiol. Dis."},{"issue":"48","key":"10.1016\/j.biopha.2025.118876_bib58","doi-asserted-by":"crossref","first-page":"16251","DOI":"10.1074\/jbc.RA119.012330","article-title":"Gallic acid is a dual \u03b1\/\u03b2-secretase modulator that reverses cognitive impairment and remediates pathology in Alzheimer mice","volume":"295","author":"Mori","year":"2020","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.biopha.2025.118876_bib59","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1080\/01480545.2020.1754849","article-title":"Nutritional supplementation of gallic acid ameliorates Alzheimer-type hippocampal neurodegeneration and cognitive impairment induced by aluminum chloride exposure in adult Wistar rats","volume":"45","author":"Ogunlade","year":"2022","journal-title":"Drug Chem. Toxicol."},{"issue":"2","key":"10.1016\/j.biopha.2025.118876_bib60","first-page":"97","article-title":"Effect of gallic acid on dementia type of alzheimer disease in rats: electrophysiological and histological studies","volume":"7","author":"Hajipour","year":"2016","journal-title":"Basic Clin. Neurosci."},{"key":"10.1016\/j.biopha.2025.118876_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115144","article-title":"Polyphenol-enriched Desmodium elegans DC. ameliorate scopolamine-induced amnesia in animal model of Alzheimer's disease: in vitro, in vivo and in silico approaches","volume":"165","author":"Mahnashi","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2025.118876_bib62","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.ejmech.2014.07.111","article-title":"Gallic acid, one of the components in many plant tissues, is a potential inhibitor for insulin amyloid fibril formation","volume":"85","author":"Jayamani","year":"2014","journal-title":"Eur. J. Med. Chem."},{"issue":"6","key":"10.1016\/j.biopha.2025.118876_bib63","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.neuron.2018.08.011","article-title":"Molecular dynamics simulation for all","volume":"99","author":"Hollingsworth","year":"2018","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.biopha.2025.118876_bib64","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12964-021-00704-3","article-title":"Baicalein inhibits heparin-induced Tau aggregation by initializing non-toxic Tau oligomer formation","volume":"19","author":"Sonawane","year":"2021","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.biopha.2025.118876_bib65","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.46924","article-title":"Structure-based inhibitors of amyloid beta core suggest a common interface with tau","volume":"8","author":"Griner","year":"2019","journal-title":"eLife"},{"issue":"50","key":"10.1016\/j.biopha.2025.118876_bib66","doi-asserted-by":"crossref","first-page":"7893","DOI":"10.1021\/bi500910b","article-title":"Capping of abeta42 oligomers by small molecule inhibitors","volume":"53","author":"Fu","year":"2014","journal-title":"Biochemistry"},{"key":"10.1016\/j.biopha.2025.118876_bib67","doi-asserted-by":"crossref","DOI":"10.2174\/0115672050386924250930184405","article-title":"Innovative approaches in molecular docking for the discovery of novel inhibitors against Alzheimer's disease","author":"Singh","year":"2025","journal-title":"Curr. Alzheimer Res."},{"issue":"3","key":"10.1016\/j.biopha.2025.118876_bib68","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28031388","article-title":"In silico drug design and analysis of dual amyloid-beta and tau protein-aggregation inhibitors for alzheimer's disease treatment","volume":"28","author":"Job","year":"2023","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.biopha.2025.118876_bib69","doi-asserted-by":"crossref","DOI":"10.3390\/antiox12020378","article-title":"Current techniques of water solubility improvement for antioxidant compounds and their correlation with its activity: molecular pharmaceutics","volume":"12","author":"Budiman","year":"2023","journal-title":"Antioxidants"},{"issue":"5","key":"10.1016\/j.biopha.2025.118876_bib70","doi-asserted-by":"crossref","DOI":"10.3390\/life13051099","article-title":"Advancement in solubilization approaches: a step towards bioavailability enhancement of poorly soluble drugs","volume":"13","author":"Kumari","year":"2023","journal-title":"Life"},{"issue":"7","key":"10.1016\/j.biopha.2025.118876_bib71","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.4103\/NRR.NRR-D-24-00048","article-title":"Liposomes as versatile agents for the management of traumatic and nontraumatic central nervous system disorders: drug stability, targeting efficiency, and safety","volume":"20","author":"Zhang","year":"2025","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.biopha.2025.118876_bib72","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.2147\/DDDT.S447496","article-title":"Advances in nanotechnology for enhancing the solubility and bioavailability of poorly soluble drugs","volume":"18","author":"Liu","year":"2024","journal-title":"Drug Des. Dev. Ther."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225010704?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225010704?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T07:08:03Z","timestamp":1777014483000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332225010704"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":72,"alternative-id":["S0753332225010704"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118876","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In silico virtual screening of natural small molecules for dual inhibition of A\u03b2 and tau aggregation in Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118876","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118876"}}